Genscript Biotech (HKSE:01548) PB Ratio : 2.42 (As of May. 15, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-15), Genscript Biotech's share price is HK$12.42. Genscript Biotech's Book Value per Share for the quarter that ended in Dec. 2023 was HK$5.12. Hence, Genscript Biotech's PB Ratio of today is 2.42.

The historical rank and industry rank for Genscript Biotech's PB Ratio or its related term are showing as below:

HKSE:01548' s PB Ratio Range Over the Past 10 Years
Min: 1.51 Med: 6.72 Max: 31.42
Current: 2.44

During the past 10 years, Genscript Biotech's highest PB Ratio was 31.42. The lowest was 1.51. And the median was 6.72.

HKSE:01548's PB Ratio is ranked better than
50.91% of 1312 companies
in the Biotechnology industry
Industry Median: 2.48 vs HKSE:01548: 2.44

During the past 12 months, Genscript Biotech's average Book Value Per Share Growth Rate was 37.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 22.40% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Genscript Biotech was 63.50% per year. The lowest was 6.10% per year. And the median was 32.80% per year.

Back to Basics: PB Ratio

Genscript Biotech PB Ratio Historical Data

The historical data trend for Genscript Biotech's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech PB Ratio Chart

Genscript Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

11.13

2.62

8.86

6.67

3.88

Genscript Biotech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial														8.86	10.11	6.67	3.51	3.88

Competitive Comparison of Genscript Biotech's PB Ratio

For the Biotechnology subindustry, Genscript Biotech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genscript Biotech's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's PB Ratio distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's PB Ratio falls into.

Genscript Biotech PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Genscript Biotech's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	12.42	/	5.123
	=	2.42

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Genscript Biotech (HKSE:01548) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Genscript Biotech PB Ratio Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech (HKSE:01548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

GNNSF:USA G51:Germany

Address

No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100

Website

https://www.genscript.com

GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, it is best known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript's valuation is from its ownership stake in Legend.

Genscript Biotech (HKSE:01548) Headlines

No Headlines